GlaxoSmithKline said on Thursday it sold its stake in Unilever's Indian business for $3.35 billion, which Refinitiv says is the largest block trade ever to have been carried out in India.
Full ArticleGlaxoSmithKline has sold its stake in Unilever's Indian business for $3.4 billion, marking India's largest block trade, which will..
GlaxoSmithKline is selling $3.45 billion worth of shares in Unilever's Indian business on the open market, one of the bookrunners..
A spokesman for GlaxoSmithKline on Wednesday declined to comment on a report by IFR, saying the British drugmaker was selling a..